Top

Published in:

09-09-2023 | Hypertension | Hypertension (DS Geller and DL Cohen, Section Editors)

The Promise and Illusion of Continuous, Cuffless Blood Pressure Monitoring

Authors: Jiun-Ruey Hu, Dae Yong Park, Nikita Agarwal, Matthew Herzig, George Ormseth, Milan Kaushik, Duc M. Giao, Ruth-Alma N. Turkson-Ocran, Stephen P. Juraschek

Published in: Current Cardiology Reports | Issue 10/2023

Abstract

Purpose of Review

Blood pressure (BP) fluctuations outside of clinic are increasingly recognized for their role in the development of cardiovascular disease, syncope, and premature death and as a promising target for tailored hypertension treatment. However, current cuff-based BP devices, including home and ambulatory devices, are unable to capture the breadth of BP variability across human activities, experiences, and contexts.

Recent Findings

Cuffless, wearable BP devices offer the promise of beat-to-beat, continuous, noninvasive measurement of BP during both awake and sleep periods with minimal patient inconvenience. Importantly, cuffless BP devices can characterize BP variability, allowing for the identification of patient-specific triggers of BP surges in the home environment. Unfortunately, the pace of evidence, regulation, and validation testing has lagged behind the pace of innovation and direct consumer marketing.

Summary

We provide an overview of the available technologies and devices for cuffless BP monitoring, considerations for the calibration and validation of these devices, and the promise and pitfalls of the cuffless BP paradigm.

O’Brien E, Fitzgerald D. The history of blood pressure measurement. J Hum Hypertens. 1994;8(2):73–84. https://www.ncbi.nlm.nih.gov/pubmed/8207743.PubMed

Swales JD. A century of arterial hypertension. J R Soc Med. 1996;89(11):658.CrossRefPubMedCentral

Janeway TC. A clinical study of hypertensive cardiovascular disease. Arch Intern Med. 1913;12:755–8.CrossRef

Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes J 3rd. Factors of risk in the development of coronary heart disease–six year follow-up experience. The Framingham Study Ann Intern Med. 1961;55:33–50. https://doi.org/10.7326/0003-4819-55-1-33.CrossRefPubMed

Treatment BPL, Trialists C. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis. Lancet. 2021;397(10285):1625–36. https://doi.org/10.1016/S0140-6736(21)00590-0.CrossRef

Group SR, Lewis CE, Fine LJ, Beddhu S, Cheung AK, Cushman WC, Cutler JA, Evans GW, Johnson KC, Kitzman DW, Oparil S, Rahman M, Reboussin DM, Rocco MV, Sink KM, Snyder JK, Whelton PK, Williamson JD, Wright JT Jr, Ambrosius WT. Final report of a trial of intensive versus standard blood-pressure control. N Engl J Med. 2021;384(20):1921–30. https://doi.org/10.1056/NEJMoa1901281.CrossRef

Johnson KC, Kostis WJ, Papademetriou V, Rahman M, Simmons DL, Taylor A, Whelton PK, Wright JT, Bhatt UY, Drawz PE. Effect of intensive and standard clinic‐based hypertension management on the concordance between clinic and ambulatory blood pressure and blood pressure variability in SPRINT. J Am Heart Assoc. 2019;8(14). https://doi.org/10.1161/jaha.118.011706

Kuznetsova T, Stolarz K, Bianchi M, Richart T, Casiglia E, Malyutina S, Filipovsky J, Kawecka-Jaszcz K, Nikitin Y, Ohkubo T, Sandoya E, Investigators I. The International Database of Ambulatory Blood Pressure in relation to Cardiovascular Outcome (IDACO): protocol and research perspectives. Blood Press Monit. 2007;12(4):255–62. https://doi.org/10.1097/mbp.0b013e3280f813bc.CrossRefPubMed

Cohen JB, Lotito MJ, Trivedi UK, Denker MG, Cohen DL, Townsend RR. Cardiovascular events and mortality in white coat hypertension. Ann Intern Med. 2019;170(12):853. https://doi.org/10.7326/m19-0223.CrossRefPubMedPubMedCentral

10.

Palla M, Saber H, Konda S, Briasoulis A. Masked hypertension and cardiovascular outcomes: an updated systematic review and meta-analysis. Integrated Blood Pressure Control. 2018;11:11–24. https://doi.org/10.2147/ibpc.s128947.CrossRefPubMedPubMedCentral

11.

Niiranen TJ, Maki J, Puukka P, Karanko H, Jula AM. Office, home, and ambulatory blood pressures as predictors of cardiovascular risk. Hypertension. 2014;64(2):281–6. https://doi.org/10.1161/HYPERTENSIONAHA.114.03292.CrossRefPubMed

12.

Schwartz JE, Muntner P, Kronish IM, Burg MM, Pickering TG, Bigger JT, Shimbo D. Reliability of office, home, and ambulatory blood pressure measurements and correlation with left ventricular mass. J Am Coll Cardiol. 2020;76(25):2911–22. https://doi.org/10.1016/j.jacc.2020.10.039.CrossRefPubMedPubMedCentral

13.

Mancia G, Verdecchia P. Clinical value of ambulatory blood pressure: evidence and limits. Circ Res. 2015;116(6):1034–45. https://doi.org/10.1161/CIRCRESAHA.116.303755.CrossRefPubMed

14.

Kuwabara M, Harada K, Hishiki Y, Ohkubo T, Kario K, Imai Y. Validation of a wrist-type home nocturnal blood pressure monitor in the sitting and supine position according to the ANSI/AAMI/ISO81060-2:2013 guidelines: Omron HEM-9601T. The Journal of Clinical Hypertension. 2020;22(6):970–8. https://doi.org/10.1111/jch.13864.CrossRefPubMedPubMedCentral

15.

Leary AC, Murphy MB. Sleep disturbance during ambulatory blood pressure monitoring of hypertensive patients. Blood Press Monit. 1998;3(1):11–5. https://www.ncbi.nlm.nih.gov/pubmed/10212326.PubMed

16.

Tolonen H, Koponen P, Naska A, Männistö S, Broda G, Palosaari T, Kuulasmaa K. Challenges in standardization of blood pressure measurement at the population level. BMC Med Res Methodol. 2015;15:33. https://doi.org/10.1186/s12874-015-0020-3.CrossRefPubMedPubMedCentral

17.

Elias MF, Goodell AL. Human errors in automated office blood pressure measurement. Hypertension. 2021;77:6–15. https://doi.org/10.1161/HYPERTENSIONAHA.120.16164.CrossRefPubMed

18.

Kario K. New insight of morning blood pressure surge into the triggers of cardiovascular disease-synergistic resonance of blood pressure variability. Am J Hypertens. 2016;29:14–6. https://doi.org/10.1093/ajh/hpv114.CrossRefPubMed

19.

Kario K. Evidence and perspectives on the 24-hour management of hypertension: hemodynamic biomarker-initiated ‘anticipation medicine’ for zero cardiovascular event. Prog Cardiovasc Dis. 2016;59:262–81. https://doi.org/10.1016/j.pcad.2016.04.001.CrossRefPubMed

20.

Julius S, Li Y, Brant D, Krause L, Buda AJ. Neurogenic pressor episodes fail to cause hypertension, but do induce cardiac hypertrophy. Hypertension. 1989;13(5):422–9.CrossRefPubMed

21.

Sabbahi A, Arena R, Kaminsky LA, Myers J, Phillips SA. Feb Peak blood pressure responses during maximum cardiopulmonary exercise testing: reference standards from FRIEND (Fitness Registry and the Importance of Exercise: a national database). Hypertension. 2018;71(2):229–36. https://doi.org/10.1161/HYPERTENSIONAHA.117.10116. Epub 18 Dec 2017. PMID: 29255072.CrossRefPubMed

22.

Assaf Y, Barout A, Alhamid A, Al-Mouakeh A, Barillas-Lara MI, Fortin-Gamero S, Bonikowske AR, Pepine CJ, Allison TG. Peak systolic blood pressure during the exercise test: reference values by sex and age and association with mortality. Hypertension. 2021;77(6):1906–14. https://doi.org/10.1161/hypertensionaha.120.16570.CrossRefPubMed

23.

Wieling W, Van Dijk N, Thijs RD, De Lange FJ, Krediet CTP, Halliwill JR. Physical countermeasures to increase orthostatic tolerance. J Intern Med. 2015;277(1):69–82. https://doi.org/10.1111/joim.12249.CrossRefPubMed

24.

Imholz BP, Wieling W, van Montfrans GA, Wesseling KH. Fifteen years experience with finger arterial pressure monitoring: assessment of the technology. Cardiovasc Res. 1998;38(3):605–16. https://doi.org/10.1016/s0008-6363(98)00067-4. PMID: 9747429.

25.

Kario K, Tomitani N, Fujiwara T, Okawara Y, Kanegae H, Hoshide S. Peak home blood pressure as an earlier and strong novel risk factor for stroke: the practitioner-based nationwide J-HOP study extended. Hypertens Res. 2023. https://doi.org/10.1038/s41440-023-01297-9.CrossRefPubMedPubMedCentral

26.

Kario K. Management of hypertension in the digital era: small wearable monitoring devices for remote blood pressure monitoring. Hypertension. 2020;76:640–50. https://doi.org/10.1161/HYPERTENSIONAHA.120.14742.CrossRefPubMed

27.

Hu J-R, Martin G, Iyengar S, Kovell LC, Plante TB, Helmond NV, Dart RA, Brady TM, Turkson-Ocran R-AN, Juraschek SP. Validating cuffless continuous blood pressure monitoring devices. Cardiovascular Digital Health Journal. 2023;4(1):9–20. https://doi.org/10.1016/j.cvdhj.2023.01.001.CrossRefPubMedPubMedCentral

28.

Stergiou G, Brunstrom M, MacDonald T, Kyriakoulis KG, Bursztyn M, Khan N, Bakris G, Kollias A, Menti A, Muntner P, Orias M, Poulter N, Shimbo D, Williams B, Adeoye AM, Damasceno A, Korostovtseva L, Li Y, Muxfeldt E, Tomaszewski M. Bedtime dosing of antihypertensive medications: systematic review and consensus statement: International Society of Hypertension position paper endorsed by World Hypertension League and European Society of Hypertension. J Hypertens. 2022;40(10):1847–58. https://doi.org/10.1097/HJH.0000000000003240.CrossRefPubMed

29.

Oliver JJ, Webb DJ. Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol. 2003;23(4):554–66. https://doi.org/10.1161/01.ATV.0000060460.52916.D6.CrossRefPubMed

30.

Tamura T. Cuffless blood pressure monitors: principles, standards and approval for medical use. IEICE Transactions on Communications. 2021;104(6):580–6. https://doi.org/10.1587/transcom.2020HMI0002.CrossRef

31.

Alexandre J, Tan K, Almeida TP, Sola J, Alpert BS, Shah J. Validation of the Aktiia blood pressure cuff for clinical use according to the ANSI/AAMI/ISO 81060–2:2013 protocol. Blood Press Monit. 2023;28(2):109–12. https://doi.org/10.1097/mbp.0000000000000639.CrossRefPubMedPubMedCentral

32.

Bradley CK, Shimbo D, Colburn DA, Pugliese DN, Padwal R, Sia SK, Anstey DE. Cuffless blood pressure devices. Am J Hypertens. 2022;35(5):380–7. https://doi.org/10.1093/ajh/hpac017.CrossRefPubMedPubMedCentral

33.

Sayer G, Piper G, Vorovich E, Raikhelkar J, Kim GH, Rodgers D, Shimbo D, Uriel N. Continuous monitoring of blood pressure using a wrist-worn cuffless device. Am J Hypertens. 2022;35(5):407–13. https://doi.org/10.1093/ajh/hpac020.CrossRefPubMed

34.

Guidance for Industry and Food and Drug Administration Staff. (2019). FDA. Maryland.

35.

• Stergiou GS, Avolio AP, Palatini P, Kyriakoulis KG, Schutte AE, Mieke S, Kollias A, Parati G, Asmar R, Pantazis N, Stamoulopoulos A, Asayama K, Castiglioni P, De La Sierra A, Hahn J-O, Kario K, McManus RJ, Myers M, Ohkubo T, Mukkamala R. European Society of Hypertension recommendations for the validation of cuffless blood pressure measuring devices: European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability. Journal of Hypertension. 9900. https://journals.lww.com/jhypertension/Fulltext/9900/European_Society_of_Hypertension_recommendations.267.aspx. This ESH recommendation is the first of its kind to require a device maintain its accuracy in the intermediate to long term as a subject responds to antihypertensive medication, diurnal variation, and exercise as a testing condition.

36.

Nair D, Tan SY, Gan HW, Lim SF, Tan J, Zhu M, Gao H, Chua NH, Peh WL, Mak KH. The use of ambulatory tonometric radial arterial wave capture to measure ambulatory blood pressure: the validation of a novel wrist-bound device in adults. J Hum Hypertens. 2008;22(3):220–2. https://doi.org/10.1038/sj.jhh.1002306.CrossRefPubMed

37.

Babs Soller, P. A blood pressure study demonstrating equivalence of the ViSi Mobile^® system and GE DINAMAPTM CARESCAPETM V100. 2019. https://cdn2.hubspot.net/hubfs/5599582/SoteraWireless-April2020/PDF/White-Paper-ViSi-Mobile-and-GE-Dinamap-Carescape-White-Paper-3.pdf

38.

Continuous Non-Invasive Blood Pressure. Sotera Digital Health. https://soteradigitalhealth.com/blog/continuous-non-invasive-blood-pressure. Accessed 12 Aug 2023.

39.

Nachman D, Gilan A, Goldstein N, Constantini K, Littman R, Eisenkraft A, et al. Twenty-four-hour ambulatory blood pressure measurement using a novel noninvasive, cuffless, wireless device. Am J Hypertens. 2021;34:1171–80. https://academic.oup.com/ajh/article/34/11/1171/6304850?login=false.PubMed

40.

Nachman D, Gepner Y, Goldstein N, Kabakov E, Ishay AB, Littman R, Azmon Y, Jaffe E, Eisenkraft A. Comparing blood pressure measurements between a photoplethysmography-based and a standard cuff-based manometry device. Sci Rep. 2020;10(1). https://doi.org/10.1038/s41598-020-73172-3.

41.

Kachel E, Constantini K, Nachman D, Carasso S, Littman R, Eisenkraft A, et al. A pilot study of blood pressure monitoring after cardiac surgery using a wearable, non-invasive sensor. Front Med. 2021;8. Available from: https://www.frontiersin.org/articles/10.3389/fmed.2021.693926.

42.

Baruch MC, Kalantari K, Gerdt DW, et al. Validation of the pulse decomposition analysis algorithm using central arterial blood pressure. BioMed Eng OnLine. 2014;13:96. https://doi.org/10.1186/1475-925X-13-96.CrossRefPubMedPubMedCentral

43.

Kwon Y, Stafford PL, Enfield K, Mazimba S, Baruch MC. Continuous noninvasive blood pressure monitoring of beat-by-beat blood pressure and heart rate using caretaker compared with invasive arterial catheter in the intensive care unit. J Cardiothorac Vasc Anesth. 2022;36(7):2012–21. https://doi.org/10.1053/j.jvca.2021.09.042.CrossRefPubMed

44.

Gratz I, Deal E, Spitz F, Baruch M, Allen IE, Seaman JE, et al. Continuous Non-invasive finger cuff CareTaker^® comparable to invasive intra-arterial pressure in patients undergoing major intra-abdominal surgery. BMC Anesthesiol. 2017;17:48. https://doi.org/10.1186/s12871-017-0337-z.CrossRefPubMedPubMedCentral

45.

Gratz I, Baruch M, Allen IE, Seaman J, Takla M, McEniry B, et al. Validation of the next-generation caretaker continuous physiological monitor using invasive intra-arterial pressures in abdominal surgery patients. Med Res Arch. 2021;9(7). https://doi.org/10.18103/mra.v9i7.2482.

46.

Mukkamala R, Stergiou GS, Avolio AP. Cuffless blood pressure measurement. Annu Rev Biomed Eng. 2022;24:203–30. https://doi.org/10.1146/annurev-bioeng-110220-014644.CrossRefPubMed

47.

Padwal R. Cuffless blood pressure measurement: how did accuracy become an afterthought? Am J Hypertens. 2019;32(9):807–9. https://doi.org/10.1093/ajh/hpz070.CrossRefPubMed

48.

• Stergiou GS, Alpert B, Mieke S, Asmar R, Atkins N, Eckert S, Frick G, Friedman B, Graßl T, Ichikawa T, Ioannidis JP, Lacy P, McManus R, Murray A, Myers M, Palatini P, Parati G, Quinn D, Sarkis J, Shennan A, Usuda T, Wang J, Wu CO, O’Brien E. A universal standard for the validation of blood pressure measuring devices: Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO) Collaboration Statement. J Hypertens. 2018;36(3):472–8. https://doi.org/10.1097/HJH.0000000000001634. PMID: 29384983; PMCID: PMC5796427. This collaboration between the AAMI, ESH, and ISO resulted in a universal standard for the validation of BP measuring devices, including six scenarios: the static position test, the device position test, the treatment test, the awake/sleep test, the exercise test, and the recalibration test.

49.

Tan I, Gnanenthiran SR, Chan J, Kyriakoulis KG, Schlaich MP, Rodgers A, Stergiou GS, Schutte AE. Evaluation of the ability of a commercially available cuffless wearable device to track blood pressure changes. J Hypertens. 2023;41(6):1003–10. https://doi.org/10.1097/hjh.0000000000003428.CrossRefPubMedPubMedCentral

50.

Mukkamala R, Shroff SG, Landry C, Kyriakoulis KG, Avolio AP, Stergiou GS. The Microsoft Research Aurora project: important findings on cuffless blood pressure measurement. Hypertension. 2023;80(3):534–40. https://doi.org/10.1161/HYPERTENSIONAHA.122.20410.CrossRefPubMed

51.

Bent B, Goldstein BA, Kibbe WA, Dunn JP. Investigating sources of inaccuracyin wearable optical heart rate sensors. Npj Digit Med. 2020;3:1–9.CrossRef

52.

Shirbani F, Hui N, Tan I, Butlin M, Avolio AP. Effect of ambient lighting and skintone on estimation of heart rate and pulse transit time from video plethysmography. Annu Int Conf IEEE Eng Med Biol Soc. 2020;2020:2642–2645.

53.

Saxena A, Minton D, Lee DC, Sui X, Fayad R, Lavie CJ, Blair SN. Protective role of resting heart rate on all-cause and cardiovascular disease mortality. Mayo Clin Proc. 2013;88(12):1420–6. https://doi.org/10.1016/j.mayocp.2013.09.011.CrossRefPubMed

54.

Ishizaka T, Takahara A, Iwasaki H, Mitsumori Y, Kise H, Nakamura Y, Sugiyama A. Cardiovascular effects of azelnidipine in comparison with those of amlodipine assessed in the halothane-anaesthetized dog. Basic Clin Pharmacol Toxicol. 2010;106(2):135–43. https://doi.org/10.1111/j.1742-7843.2009.00478.x.CrossRefPubMed

55.

Bostock Y, Hanley J, McGown D, Pinnock H, Padfield P, McKinstry B. The acceptability to patients and professionals of remote blood pressure monitoring using mobile phones. Primary Health Care Res Develop. 2009;10:299–308.CrossRef

56.

Bakkar N-MZ, El-Yazbi AF, Zouein FA, Fares SA. Beat-to-beat blood pressure variability: an early predictor of disease and cardiovascular risk. J Hypertens. 2021;39(5):830–845.

57.

Rothwell PM. Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. The Lancet. 2010;375(9718):938–48.CrossRef

58.

Webb AJ, Mazzucco S, Li L, Rothwell PM. Prognostic significance of blood pressure variability on beat-to-beat monitoring after transient ischemic attack and stroke. Stroke. 2018;49(1):62–7.CrossRefPubMed

59.

Palatini P. Blood pressure behaviour during physical activity. Sports Med. 1988;5:353–74.CrossRefPubMed

60.

Cornelissen V, Verheyden B, Aubert A, Fagard R. Effects of aerobic training intensity on resting, exercise and post-exercise blood pressure, heart rate and heart-rate variability. J Hum Hypertens. 2010;24(3):175–82.CrossRefPubMed

61.

Palatini P, Mos L, Munari L, et al. Blood pressure changes during heavy-resistance exercise. Journal of hypertension Supplement: official journal of the International Society of Hypertension. 1989;7(6):S72–3.CrossRefPubMed

62.

Hedman K, Lindow T, Elmberg V, Brudin L, Ekström M. Age-and gender-specific upper limits and reference equations for workload-indexed systolic blood pressure response during bicycle ergometry. Eur J Prev Cardiol. 2021;28(12):1360–9.CrossRefPubMed

63.

Kario K. Orthostatic hypertension a measure of blood pressure variation for predicting cardiovascular risk. Circ J. 2009;73(6):1002–7.CrossRefPubMed

64.

Spatz ES, Martinez-Brockman JL, Tessier-Sherman B, et al. Phenotypes of hypertensive ambulatory blood pressure patterns: design and rationale of the ECHORN Hypertension Study. Ethn Dis. 2019;29(4):535.CrossRefPubMedPubMedCentral

65.

Compagnat M, Mandigout S, Batcho C, et al. Validity of wearable actimeter computation of total energy expenditure during walking in post-stroke individuals. Ann Phys Rehabil Med. 2020;63(3):209–15.CrossRefPubMed

66.

Keyes A, Woerwag-Mehta S, Bartholdy S, et al. Physical activity and the drive to exercise in anorexia nervosa. Int J Eat Disord. 2015;48(1):46–54.CrossRefPubMed

67.

Natale P, Ni JY, Martinez-Martin D, et al. Perspectives and experiences of self-monitoring of blood pressure among patients with hypertension: a systematic review of qualitative studies. Am J Hypertens. 2023;hpad021. https://doi.org/10.1093/ajh/hpad021. Epub ahead of print. PMID: 36840919.

68.

Grace SL, Taherzadeh G, Jae Chang IS, Boger J, Arcelus A, Mak S, Chessex C, Mihailidis A. Perceptions of seniors with heart failure regarding autonomous zero-effort monitoring of physiological parameters in the smart-home environment. Heart Lung. 2017;46:313–9.CrossRefPubMed

69.

Tompson AC, Schwartz CL, Fleming S, Ward AM, Greenfield SM, Grant S, Hobbs FR, Heneghan CJ, McManus RJ. Patient experience of home and waiting room blood pressure measurement: a qualitative study of patients with recently diagnosed hypertension. Br J Gen Pract. 2018;68:e835–43.CrossRefPubMedPubMedCentral

70.

Bengtsson U, Kasperowski D, Ring L, Kjellgren K. Developing an interactive mobile phone self-report system for self-management of hypertension. Part 1: patient and professional perspectives. Blood Press. 2014;23:288–295.

71.

Abdullah A, Othman S. The influence of self-owned home blood pressure monitoring (HBPM) on primary care patients with hypertension: a qualitative study. BMC Fam Pract. 2011;12:143.CrossRefPubMedPubMedCentral

72.

Knorr K, Aspinall D, Wolters M. On the privacy, security and safety of blood pressure and diabetes apps. https://groups.inf.ed.ac.uk/security/appguarden/papers/healthapp-sec.pdf

73.

Al-Rousan T, Pesantes MA, Dadabhai S, Kandula NR, Huffman MD, Miranda JJ, Vidal-Perez R, Dzudie A, Anderson CAM. Patients’ perceptions of self-management of high blood pressure in three low- and middle-income countries: findings from the BPMONITOR study. Glob Health Epidemiol Genom. 2020;5: e4.CrossRefPubMedPubMedCentral

Title: The Promise and Illusion of Continuous, Cuffless Blood Pressure Monitoring
Authors: Jiun-Ruey Hu
Dae Yong Park
Nikita Agarwal
Matthew Herzig
George Ormseth
Milan Kaushik
Duc M. Giao
Ruth-Alma N. Turkson-Ocran
Stephen P. Juraschek
Publication date: 09-09-2023
Publisher: Springer US
Keywords: Hypertension
Prevention and Rehabilitation in Cardiology
Telemonitoring in Cardiology
Cardiology
Published in: Current Cardiology Reports / Issue 10/2023
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI: https://doi.org/10.1007/s11886-023-01932-4

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

At a glance: The STEP trials

Springer Medicine

The Promise and Illusion of Continuous, Cuffless Blood Pressure Monitoring

Abstract

Purpose of Review

Recent Findings

Summary

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 10/2023

Improving Hypertension Control in Vulnerable Populations Around the World

The Effect of EECP on Ischemic Heart Failure: a Systematic Review

Role of arterial stiffness in cardiovascular health

Race as a Component of Cardiovascular Disease Risk Prediction Algorithms

Update on Transcatheter Treatment of Mitral and Tricuspid Valve Regurgitation

Training pathways in critical care cardiology

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page